Licensing Executives Society
CBI’s 3rd Annual Life Sciences Congress on Paragraph IV Disputes
Speaker “Pre-Litigation Strategy, Analysis and Preparation for PIV Disputes,”
ACI’s Paragraph IV Disputes Conference
Speaker “Pharmaceutical Patent Invalidity Challenge Score Card: District Courts v. The PTAB,”
Biosimilars Clinical Studies & Analytical Similarity Summit
Speaker “Legal & Regulatory Implications of ‘Similarity’ and ‘Interchangeability,”
World Generic Medicines Congress
Speaker, Update from the U.S.: Regulatory Exclusivities, Biosimilars Progress and New Court Decisions,”
Fordham University School of Law IP Summit
Speaker “Latest Developments in Pharma/Life Sciences Patent Litigation,”
14th Annual Business of Biosimilars Conference
Speaker, “Understanding the Nuts and Bolts of Biosimilar Regulatory Requirements,”
Momentum’s International Congress on Paragraph IV Litigation
Speaker, “Litigation Management Strategy Discussion,”
FDLI’s conference on IP Throughout the Drug Development Lifecycle
Speaker, “Third Party IP: Preserving Freedom to Operate,”
ACI Conference on Paragraph IV Disputes